{"id":63,"date":"2019-06-26T09:14:44","date_gmt":"2019-06-26T09:14:44","guid":{"rendered":"http:\/\/lumen.international\/lumen-nashs2019\/?page_id=63"},"modified":"2019-06-26T09:14:55","modified_gmt":"2019-06-26T09:14:55","slug":"cope-best-practice-guidelines","status":"publish","type":"page","link":"http:\/\/lumen.international\/lumen-nashs2019\/full-paper-publication\/cope-best-practice-guidelines\/","title":{"rendered":"COPE \u2013 Best Practice Guidelines"},"content":{"rendered":"<p><span style=\"font-size: 12pt;\">LUMEN, as member of COPE, aims at complying \u00a0with the\u00a0Codes of Conduct and Best Practice Guidelines and in order for our users to be up- to \u2013 date regarding the guidelines that COPE is expressing in order to sustain and develop a good practice in editorial processes, we expose some extracts from the\u00a0<a href=\"http:\/\/publicationethics.org\/resources\/code-conduct\" target=\"_blank\" rel=\"noopener\">Code of Conduct and Best Practice Guidelines for Journal Editors<\/a>, as it follows:<\/span><\/p>\n<p><span style=\"font-size: 12pt;\"><strong>***<\/strong><\/span><\/p>\n<p><span style=\"font-size: 12pt;\"><strong>\u201c7. Editorial and peer review processes<\/strong><\/span><br \/>\n<span style=\"font-size: 12pt;\">7.1. Editors should strive to ensure that peer review at their journal is fair, unbiased and timely.<\/span><br \/>\n<span style=\"font-size: 12pt;\">7.2. Editors should have systems to ensure that material submitted to their journal remains<\/span><br \/>\n<span style=\"font-size: 12pt;\">confidential while under review.<\/span><br \/>\n<span style=\"font-size: 12pt;\">Best practice for editors would include:<\/span><br \/>\n<span style=\"font-size: 12pt;\">\u2022 ensuring that people involved with the editorial process (including themselves) receive adequate<\/span><br \/>\n<span style=\"font-size: 12pt;\">training and keep abreast of the latest guidelines, recommendations and evidence about peer review<\/span><br \/>\n<span style=\"font-size: 12pt;\">and journal management<\/span><br \/>\n<span style=\"font-size: 12pt;\">\u2022 keeping informed about research into peer review and technological advances<\/span><br \/>\n<span style=\"font-size: 12pt;\">\u2022 adopting peer review methods best suited for their journal and the research community it serves<\/span><br \/>\n<span style=\"font-size: 12pt;\">\u2022 reviewing peer review practices periodically to see if improvement is possible<\/span><br \/>\n<span style=\"font-size: 12pt;\">\u2022 referring troubling cases to COPE, especially when questions arise that are not addressed by the<\/span><br \/>\n<span style=\"font-size: 12pt;\">COPE flowcharts, or new types of publication misconduct are suspected<\/span><br \/>\n<span style=\"font-size: 12pt;\">\u2022 considering the appointment of an ombudsperson to adjudicate in complaints that cannot be<\/span><br \/>\n<span style=\"font-size: 12pt;\">resolved internally<\/span><\/p>\n<p><span style=\"font-size: 12pt;\"><strong>8. Quality assurance<\/strong><\/span><br \/>\n<span style=\"font-size: 12pt;\">8.1. Editors should take all reasonable steps to ensure the quality of the material they publish,<\/span><br \/>\n<span style=\"font-size: 12pt;\">recognising that journals and sections within journals will have different aims and standards.<\/span><br \/>\n<span style=\"font-size: 12pt;\">Best practice for editors would include:<\/span><br \/>\n<span style=\"font-size: 12pt;\">\u2022 having systems in place to detect falsified data (e.g. inappropriately manipulated photographic<\/span><br \/>\n<span style=\"font-size: 12pt;\">images or plagiarised text) either for routine use or when suspicions are raised<\/span><br \/>\n<span style=\"font-size: 12pt;\">\u2022 basing decisions about journal house style on relevant evidence of factors that raise the quality of<\/span><br \/>\n<span style=\"font-size: 12pt;\">reporting (e.g. adopting structured abstracts, applying guidance such as CONSORT2) rather than<\/span><br \/>\n<span style=\"font-size: 12pt;\">simply on aesthetic grounds or personal preference.<\/span><\/p>\n<p><span style=\"font-size: 12pt;\"><strong>9. Protecting individual data<\/strong><\/span><br \/>\n<span style=\"font-size: 12pt;\">9.1. Editors must obey laws on confidentiality in their own jurisdiction. Regardless of local statutes,<\/span><br \/>\n<span style=\"font-size: 12pt;\">however, they should always protect the confidentiality of individual information obtained in<\/span><br \/>\n<span style=\"font-size: 12pt;\">the course of research or professional interactions (e.g. between doctors and patients). It is<\/span><br \/>\n<span style=\"font-size: 12pt;\">therefore almost always necessary to obtain written informed consent for publication from<\/span><br \/>\n<span style=\"font-size: 12pt;\">people who might recognise themselves or be identified by others (e.g. from case reports or<\/span><br \/>\n<span style=\"font-size: 12pt;\">photographs). It may be possible to publish individual information without explicit consent if<\/span><br \/>\n<span style=\"font-size: 12pt;\">public interest considerations outweigh possible harms, it is impossible to obtain consent and a<\/span><br \/>\n<span style=\"font-size: 12pt;\">reasonable individual would be unlikely to object to publication.<\/span><br \/>\n<span style=\"font-size: 12pt;\">Best practice for editors would include:<\/span><br \/>\n<span style=\"font-size: 12pt;\">\u2022 publishing their policy on publishing individual data (e.g. identifiable personal details or images) and<\/span><br \/>\n<span style=\"font-size: 12pt;\">explaining this clearly to authors<\/span><br \/>\n<span style=\"font-size: 12pt;\">Note that consent to take part in research or undergo treatment is not the same as consent to publish<\/span><br \/>\n<span style=\"font-size: 12pt;\">personal details, images or quotations.<\/span><\/p>\n<p><span style=\"font-size: 12pt;\"><strong>10. Encouraging ethical research (e.g. research involving humans or animals)<\/strong><\/span><br \/>\n<span style=\"font-size: 12pt;\">10.1. Editors should endeavour to ensure that research they publish was carried out according to the<\/span><br \/>\n<span style=\"font-size: 12pt;\">relevant internationally accepted guidelines (e.g. the Declaration of Helsinki<\/span><br \/>\n<span style=\"font-size: 12pt;\">for clinical research,the AERA and BERA guidelines for educational research).<\/span><br \/>\n<span style=\"font-size: 12pt;\">10.2. Editors should seek assurances that all research has been approved by an appropriate body<\/span><br \/>\n<span style=\"font-size: 12pt;\">(e.g. research ethics committee, institutional review board) where one exists. However, editors<\/span><br \/>\n<span style=\"font-size: 12pt;\">should recognise that such approval does not guarantee that the research is ethical.<\/span><br \/>\n<span style=\"font-size: 12pt;\">Best practice for editors would include:<\/span><br \/>\n<span style=\"font-size: 12pt;\">\u2022 being prepared to request evidence of ethical research approval and to question authors about<\/span><br \/>\n<span style=\"font-size: 12pt;\">ethical aspects (such as how research participant consent was obtained or what methods were<\/span><br \/>\n<span style=\"font-size: 12pt;\">employed to minimize animal suffering) if concerns are raised or clarifications are needed<\/span><br \/>\n<span style=\"font-size: 12pt;\">\u2022 ensuring that reports of clinical trials cite compliance with the Declaration of Helsinki8, Good Clinical<\/span><br \/>\n<span style=\"font-size: 12pt;\">Practice<\/span><br \/>\n<span style=\"font-size: 12pt;\">and other relevant guidelines to safeguard participants<\/span><br \/>\n<span style=\"font-size: 12pt;\">\u2022 ensuring that reports of experiments on, or studies of, animals cite compliance with the US<\/span><br \/>\n<span style=\"font-size: 12pt;\">Department of Health and Human Services Guide for the Care and Use of Laboratory Animals<\/span><br \/>\n<span style=\"font-size: 12pt;\">or\u00a0other relevant guidelines<\/span><br \/>\n<span style=\"font-size: 12pt;\">\u2022 appointing a journal ethics advisor or panel to advise on specific cases and review journal policies<\/span><br \/>\n<span style=\"font-size: 12pt;\">periodically<\/span><\/p>\n<p><span style=\"font-size: 12pt;\"><strong>11. Dealing with possible misconduct<\/strong><\/span><br \/>\n<span style=\"font-size: 12pt;\">11.1. Editors have a duty to act if they suspect misconduct or if an allegation of misconduct is brought<\/span><br \/>\n<span style=\"font-size: 12pt;\">to them. This duty extends to both published and unpublished papers.<\/span><br \/>\n<span style=\"font-size: 12pt;\">11.2. Editors should not simply reject papers that raise concerns about possible misconduct. They are<\/span><br \/>\n<span style=\"font-size: 12pt;\">ethically obliged to pursue alleged cases.<\/span><br \/>\n<span style=\"font-size: 12pt;\">11.3. Editors should follow the COPE flowcharts\u00a0where applicable.<\/span><br \/>\n<span style=\"font-size: 12pt;\">11.4. Editors should first seek a response from those suspected of misconduct. If they are not<\/span><br \/>\n<span style=\"font-size: 12pt;\">satisfied with the response, they should ask the relevant employers, or institution, or some<\/span><br \/>\n<span style=\"font-size: 12pt;\">appropriate body (perhaps a regulatory body or national research integrity organization) to<\/span><br \/>\n<span style=\"font-size: 12pt;\">investigate.<\/span><br \/>\n<span style=\"font-size: 12pt;\">11.5. Editors should make all reasonable efforts to ensure that a proper investigation into alleged<\/span><br \/>\n<span style=\"font-size: 12pt;\">misconduct is conducted; if this does not happen, editors should make all reasonable attempts<\/span><br \/>\n<span style=\"font-size: 12pt;\">to persist in obtaining a resolution to the problem. This is an onerous but important duty.<\/span><\/p>\n<p><span style=\"font-size: 12pt;\"><strong>12. Ensuring the integrity of the academic record<\/strong><\/span><br \/>\n<span style=\"font-size: 12pt;\">12.1. Errors, inaccurate or misleading statements must be corrected promptly and with due<\/span><br \/>\n<span style=\"font-size: 12pt;\">prominence.<\/span><br \/>\n<span style=\"font-size: 12pt;\">12.2. Editors should follow the COPE guidelines on retractions<\/span><br \/>\n<span style=\"font-size: 12pt;\">Best practice for editors would include:<\/span><br \/>\n<span style=\"font-size: 12pt;\">\u2022 taking steps to reduce covert redundant publication (e.g. by requiring all clinical trials to be<\/span><br \/>\n<span style=\"font-size: 12pt;\">registered)<\/span><br \/>\n<span style=\"font-size: 12pt;\">\u2022 ensuring that published material is securely archived (e.g. via online permanent repositories, such as<\/span><br \/>\n<span style=\"font-size: 12pt;\">PubMed Central)<\/span><br \/>\n<span style=\"font-size: 12pt;\">\u2022 having systems in place to give authors the opportunity to make original research articles freely<\/span><br \/>\n<span style=\"font-size: 12pt;\">available.<\/span><\/p>\n<p><span style=\"font-size: 12pt;\"><strong>13. Intellectual property<\/strong><\/span><br \/>\n<span style=\"font-size: 12pt;\">13.1. Editors should be alert to intellectual property issues and work with their publisher to handle<\/span><br \/>\n<span style=\"font-size: 12pt;\">potential breaches of intellectual property laws and conventions.<\/span><br \/>\n<span style=\"font-size: 12pt;\">Best practice for editors would include:<\/span><br \/>\n<span style=\"font-size: 12pt;\">\u2022 adopting systems for detecting plagiarism (e.g. software, searching for similar titles) in submitted<\/span><br \/>\n<span style=\"font-size: 12pt;\">items (either routinely or when suspicions are raised)<\/span><br \/>\n<span style=\"font-size: 12pt;\">\u2022 supporting authors whose copyright has been breached or who have been the victims of plagiarism<\/span><br \/>\n<span style=\"font-size: 12pt;\">\u2022 being prepared to work with their publisher to defend authors\u2019 rights and pursue offenders (e.g.<\/span><br \/>\n<span style=\"font-size: 12pt;\">by requesting retractions or removal of material from websites) irrespective of whether their journal<\/span><br \/>\n<span style=\"font-size: 12pt;\">holds the copyright.<\/span><\/p>\n<p><span style=\"font-size: 12pt;\"><strong>14. Encouraging debate<\/strong><\/span><br \/>\n<span style=\"font-size: 12pt;\">14.1. Editors should encourage and be willing to consider cogent criticisms of work published in their<\/span><br \/>\n<span style=\"font-size: 12pt;\">journal.<\/span><br \/>\n<span style=\"font-size: 12pt;\">14.2. Authors of criticised material should be given the opportunity to respond.<\/span><br \/>\n<span style=\"font-size: 12pt;\">14.3. Studies reporting negative results should not be excluded.<\/span><br \/>\n<span style=\"font-size: 12pt;\">Best practice for editors would include:<\/span><br \/>\n<span style=\"font-size: 12pt;\">\u2022 being open to research that challenges previous work published in the journal.<\/span><\/p>\n<p><span style=\"font-size: 12pt;\"><strong>15. Complaints<\/strong><\/span><br \/>\n<span style=\"font-size: 12pt;\">15.1. Editors should respond promptly to complaints and should ensure there is a way for dissatisfied<\/span><br \/>\n<span style=\"font-size: 12pt;\">complainants to take complaints further. This mechanism should be made clear in the journal<\/span><br \/>\n<span style=\"font-size: 12pt;\">and should include information on how to refer unresolved matters to COPE.<\/span><br \/>\n<span style=\"font-size: 12pt;\">15.2. Editors should follow the procedure set out in the COPE flowchart on complaints.<\/span><\/p>\n<p><span style=\"font-size: 12pt;\"><strong>16. Commercial considerations<\/strong><\/span><br \/>\n<span style=\"font-size: 12pt;\">16.1. Journals should have policies and systems in place to ensure that commercial considerations do<\/span><br \/>\n<span style=\"font-size: 12pt;\">not affect editorial decisions (e.g. advertising departments should operate independently from<\/span><br \/>\n<span style=\"font-size: 12pt;\">editorial departments).<\/span><br \/>\n<span style=\"font-size: 12pt;\">16.2. Editors should have declared policies on advertising in relation to the content of the journal and<\/span><br \/>\n<span style=\"font-size: 12pt;\">on processes for publishing sponsored supplements.<\/span><br \/>\n<span style=\"font-size: 12pt;\">16.3. Reprints should be published as they appear in the journal unless a correction needs to be<\/span><br \/>\n<span style=\"font-size: 12pt;\">included in which case it should be clearly identified.<\/span><br \/>\n<span style=\"font-size: 12pt;\">Best practice for editors would include:<\/span><br \/>\n<span style=\"font-size: 12pt;\">\u2022 publishing a general description of their journal\u2019s income sources (e.g. the proportions received from<\/span><br \/>\n<span style=\"font-size: 12pt;\">display advertising, reprint sales, sponsored supplements, page charges, etc.)<\/span><br \/>\n<span style=\"font-size: 12pt;\">\u2022 ensuring that the peer review process for sponsored supplements is the same as that used for the<\/span><br \/>\n<span style=\"font-size: 12pt;\">main journal<\/span><br \/>\n<span style=\"font-size: 12pt;\">\u2022 ensuring that items in sponsored supplements are accepted solely on the basis of academic merit<\/span><br \/>\n<span style=\"font-size: 12pt;\">and interest to readers and decisions about such supplements are not influenced by commercial<\/span><br \/>\n<span style=\"font-size: 12pt;\">considerations.<\/span><\/p>\n<p><span style=\"font-size: 12pt;\"><strong>17. Conflicts of interest<\/strong><\/span><br \/>\n<span style=\"font-size: 12pt;\">17.1. Editors should have systems for managing their own conflicts of interest as well as those of their<\/span><br \/>\n<span style=\"font-size: 12pt;\">staff, authors, reviewers and editorial board members.<\/span><br \/>\n<span style=\"font-size: 12pt;\">17.2. Journals should have a declared process for handling submissions from the editors, employees<\/span><br \/>\n<span style=\"font-size: 12pt;\">or members of the editorial board to ensure unbiased review<\/span><br \/>\n<span style=\"font-size: 12pt;\">Best practice for editors would include:<\/span><br \/>\n<span style=\"font-size: 12pt;\">\u2022 publishing lists of relevant interests (financial, academic and other kinds) of all editorial staff and<\/span><br \/>\n<span style=\"font-size: 12pt;\">members of editorial boards (which should be updated at least annually)\u201d<\/span><\/p>\n<p><span style=\"font-size: 12pt;\"><strong>Source: \u00a0COPE \u2013\u00a0\u00a0<a href=\"http:\/\/publicationethics.org\/resources\/code-conduct\" target=\"_blank\" rel=\"noopener\">Code of Conduct and Best Practice Guidelines for Journal Editors<\/a>\u00a0available online at\u00a0http:\/\/publicationethics.org\/resources\/code-conduct<\/strong><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>LUMEN, as member of COPE, aims at complying \u00a0with the\u00a0Codes of Conduct and Best Practice Guidelines and in order for our users to be up- to \u2013 date regarding the guidelines that COPE is expressing in order to sustain and develop a good practice in editorial processes, we expose some extracts from the\u00a0Code of Conduct &hellip; <a href=\"http:\/\/lumen.international\/lumen-nashs2019\/full-paper-publication\/cope-best-practice-guidelines\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;COPE \u2013 Best Practice Guidelines&#8221;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":40,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-63","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"http:\/\/lumen.international\/lumen-nashs2019\/wp-json\/wp\/v2\/pages\/63","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/lumen.international\/lumen-nashs2019\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/lumen.international\/lumen-nashs2019\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/lumen.international\/lumen-nashs2019\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/lumen.international\/lumen-nashs2019\/wp-json\/wp\/v2\/comments?post=63"}],"version-history":[{"count":2,"href":"http:\/\/lumen.international\/lumen-nashs2019\/wp-json\/wp\/v2\/pages\/63\/revisions"}],"predecessor-version":[{"id":65,"href":"http:\/\/lumen.international\/lumen-nashs2019\/wp-json\/wp\/v2\/pages\/63\/revisions\/65"}],"up":[{"embeddable":true,"href":"http:\/\/lumen.international\/lumen-nashs2019\/wp-json\/wp\/v2\/pages\/40"}],"wp:attachment":[{"href":"http:\/\/lumen.international\/lumen-nashs2019\/wp-json\/wp\/v2\/media?parent=63"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}